Safety of long-acting beta-agonists: urgent need to clear the air remains

Eur Respir J. 2009 Jan;33(1):3-5. doi: 10.1183/09031936.00163408.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Adrenergic beta-Agonists / administration & dosage
  • Adrenergic beta-Agonists / adverse effects*
  • Albuterol / administration & dosage
  • Albuterol / adverse effects
  • Albuterol / analogs & derivatives*
  • Asthma / drug therapy*
  • Asthma / mortality*
  • Ethanolamines / administration & dosage
  • Ethanolamines / adverse effects*
  • Formoterol Fumarate
  • Glucocorticoids / therapeutic use
  • Humans
  • Salmeterol Xinafoate

Substances

  • Adrenergic beta-Agonists
  • Ethanolamines
  • Glucocorticoids
  • Salmeterol Xinafoate
  • Albuterol
  • Formoterol Fumarate